FaceHeart is a digital health company that measures vital signs through a simple facial video scan using artificial intelligence. The software interprets subtle color changes in the skin to calculate heart rate and respiration rate in less than a minute. By eliminating the need for wearable sensors or in-person appointments, FaceHeart allows patients and providers to track health quickly and efficiently. The technology runs on smartphones, tablets, and other devices, making it available in clinics, homes, and workplaces. Developers can integrate the system into existing platforms, extending use across personal and professional settings.

The process begins with a brief facial scan, after which AI algorithms analyze the data to provide immediate readings. Patients can view results on-screen, while healthcare professionals receive the data for evaluation. By relying on video rather than physical devices, FaceHeart removes obstacles for users who prefer non-intrusive health tracking. The system supports routine monitoring without disrupting daily life and reduces dependency on specialized equipment.

FDA Clearance Establishes Trust

FaceHeart Vitals received FDA 510(k) clearance as a Class II Software as a Medical Device. The approval covers heart rate and respiration rate, marking it as the first video-based vital sign tool to achieve such recognition. The authorization confirms that measurements meet medical standards and can be used reliably in patient care. Users gain access to clinically validated readings without relying on traditional monitoring equipment.

Accuracy remains central to the design alongside convenience. Studies show readings remain consistent across different lighting conditions and skin tones. Clinicians can rely on the results when evaluating patient health, while patients benefit from a dependable tool for independent monitoring. Integration into digital health platforms ensures the technology delivers reliable results while remaining broadly accessible.

Applications Extend Beyond Clinics

FaceHeart technology works across a range of environments. Hospitals can screen patients quickly while minimizing direct contact, supporting hygiene standards. Schools, workplaces, and homes also gain access to video-based monitoring, offering early insight into health trends without specialized devices. Beta features under development include biomarkers such as HbA1c, hemoglobin, and cholesterol, signaling potential expansion in health tracking capabilities.

The software adapts to multiple scenarios. Remote or underserved areas gain access to vital sign monitoring where conventional devices are unavailable. Users can perform routine checks and share data instantly with healthcare providers. This flexibility allows video-based monitoring to reach populations that have faced barriers to regular health checks.

Empowering Users and Providers with Seamless Monitoring

Home users can track trends over time without scheduling appointments, while clinicians gain tools that reduce the need for extended checkups. Video-based monitoring supports frequent measurements without inconvenience, helping maintain continuous awareness of vital signs. The system encourages repeated use, creating a feedback loop that supports informed decisions and healthier routines.

How AI Captures Vital Signs Instantly

The 50-second scan captures small changes in skin tone caused by blood flow, and AI interprets these signals to calculate heart and respiration rates. Results appear immediately, giving users the ability to act or share findings with doctors without delay. By removing the need for wearable devices or specialized equipment, the software can be used in nearly any setting.

Developers find integration straightforward, and the software is compatible with a wide range of devices. Digital health providers can add monitoring to existing platforms, extending functionality without increasing complexity. Users experience seamless tracking, while healthcare professionals gain access to reliable real-time data.

Accuracy and Reliability Through FDA Clearance

FaceHeart prioritizes accuracy and reliability. FDA clearance confirms that readings meet clinical standards, and testing shows consistent performance across different environments. Expanding biomarkers could widen the scope of insights available from a single scan, allowing more comprehensive health tracking.

Accessibility remains a key focus. Users can check vital signs multiple times a day and share readings instantly with caregivers or medical professionals. Remote monitoring offers an alternative in areas where traditional devices are limited, helping address gaps in preventive care. Frequent, easy-to-use monitoring supports regular engagement with personal health.

The user experience centers on simplicity. Short scanning times and non-intrusive methods allow repeated use without disruption. Regular monitoring creates a continuous flow of data and feedback, supporting informed decision-making over time.

Future developments include additional biomarkers and deeper integration into health platforms. Partnerships with medical institutions and technology providers could position video-based vital sign monitoring as a standard option in digital healthcare. By applying AI to facial scans, FaceHeart offers a new way to track vital signs beyond conventional methods.

Rapid readings and minimal disruption align with growing demand for tools that support daily health. Users can check vital signs multiple times per day and receive immediate results. This balance of convenience and reliability positions FaceHeart as a link between digital innovation and everyday health management.

Traditional monitoring relied on in-person visits or wearable devices. Video-based AI removes those limitations, delivering a comprehensive snapshot of vital signs from a simple scan. FaceHeart reflects a broader shift in digital health, where non-contact monitoring and AI interpretation extend care into daily life.

The software delivers accurate, fast, and adaptable monitoring. Users can track early warning signs, manage ongoing conditions, or complete routine checks without extra steps or equipment. Expansion of biomarkers and wider platform integration could further extend the technology’s reach across diverse settings.

FaceHeart demonstrates that digital health tools can deliver accuracy and convenience simultaneously. The company’s focus on FDA clearance, flexible integration, and user-centered design reflects a broader movement toward accessible technology for everyday health. Video-based vital sign monitoring is now available, giving people new ways to measure and understand their health.

A Vision for Accessible Health

FaceHeart focuses on simplifying health management by providing fast and easy-to-use monitoring tools. A brief facial scan produces meaningful readings, allowing people to track vital signs with minimal effort. Partnerships with medical providers and technology companies extend the software’s reach, making routine monitoring less disruptive and more frequent. The emphasis on speed, comfort, and integration shows how digital tools can support traditional healthcare practices.

Dr. Morris Chung, Co-Founder & Marketing Director, FaceHeart